Related Experiment Video

Updated: Aug 9, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Peutz-Jeghers syndrome and management recommendations

Francis M Giardiello1, Jill D Trimbath

  • 1Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|April 18, 2006
PubMed

Insights

Peutz-Jeghers syndrome (PJS) is an inherited disorder causing gastrointestinal polyps and skin pigmentation. Individuals with PJS face a higher risk of developing various cancers, necessitating specific management strategies.

Area of Science:

  • Genetics and Oncology
  • Gastroenterology
  • Hereditary Cancer Syndromes

Background:

  • Peutz-Jeghers syndrome (PJS) is an autosomal dominant genetic disorder.
  • It results from germline mutations in the serine threonine kinase 11 (STK11) gene.
  • PJS is characterized by hamartomatous polyps in the gastrointestinal tract and mucocutaneous melanin pigmentation.

Purpose of the Study:

  • To review the clinical characteristics of Peutz-Jeghers syndrome.
  • To assess the malignancy risk associated with PJS.
  • To provide management and surveillance recommendations for PJS patients.

Main Methods:

  • Literature review of current scientific publications on Peutz-Jeghers syndrome.
  • Analysis of clinical data and epidemiological studies.
  • Synthesis of management and surveillance guidelines.

Main Results:

  • PJS patients exhibit characteristic hamartomatous polyps and mucocutaneous pigmentation.
  • There is a significantly increased risk of both common and rare gastrointestinal and non-gastrointestinal tumors in individuals with PJS.
  • Early detection and regular monitoring are crucial for managing PJS-associated risks.

Conclusions:

  • Peutz-Jeghers syndrome requires comprehensive clinical evaluation and long-term surveillance.
  • Management strategies should focus on polyp removal and vigilant cancer screening.
  • Understanding the genetic basis and cancer predisposition is key for effective patient care.

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...